Results

Total Results: 1,571 records

Showing results for "discussed".

201. Disposition of Comments Report for Otitis Media With Effusion (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
     May 04, 2013 - The significance of the study’s findings was discussed in an editorial accompanying the study’s final … Further details are discussed below in the second comment concerning page ES-10 of the CER. … Many of these findings are discussed in relation to KQ2 (functional outcomes) in the ES. … Many of these findings are discussed in relation to KQ2 (functional outcomes). … The issue of the developmental importance of the time-to-improvement is not directly discussed.

202. Disposition of Comments for CER 201 Effectiveness of Indoor Allergen Reduction in the Management of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-201-indoor-allergen-asthma-disposition-comments.pdf
     February 15, 2018 - Limitations are clear and discussed in the context of the review process as well as the evidence base

203. Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
     October 27, 2015 - There are 2 areas that were not specifically discussed. 1. … The cost implications of added technology and markers was not discussed and considering the fact that

204. Disposition of Comments Report for CER 203 ADHD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
     January 01, 2018 - The limitations of addressing larger trials within the context of this update is now discussed. … The issue of height change is discussed as appropriate under Detailed Synthesis – Pharmacologic Versus … The role of "big data" and electronic medical records is now discussed.

205. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
     April 25, 2013 - the conclusions seem reasonable, but again the clinical importance of much of these will need to be discussed … That assumes (dangerously) that if each of the PAH-specific drugs being discussed have efficacy, that … In fact, most of what is discussed in KQ2 does not add at all to clinical practice. … of the discussion and conclusions are lost in the length of the overall text and would be better discussed … However the study discussed in this section examined patients referred for PH evaluation who had symptoms

206. CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
     October 11, 2019 - The clinical context of the findings in Table 1 was discussed in the following paragraphs.

207. Disposition of Comments Report for Childhood Obesity Prevention Programs: A Comparative Effectiveness Review and Meta-Analysis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_disposition-comments.pdf
     June 10, 2013 - This was an applicability issue and is discussed in the discussion. 37 TEP 2 General Comments … We have also discussed the results of this review in light of current literature (please see Discussion … The reasons might be discussed in more depth. … We discussed this issue during the early stages of the study. … these interventions achieved, and how meaningful this change is clinically and practically could be discussed

208. Disposition of Comments: Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-nerve-blocks-disposition-comments.pdf
     August 15, 2025 - Disposition of Comments: Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery: A Systematic Review Systematic Review Disposition of Comments Report Title: Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery: A Systematic Review Dr…

209. Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
     March 29, 2016 - diagnosis of obstructive CAD and as such is really not comparable to any of the other tests that are discussed … Under Disadvantages - Would remove "Costly", as discussed above and would remove "Long procedure time … p.11 - again, CACS should be removed since it is a screening test quite different from the others discussed … The reasons for the significantly small number of studies should be discussed. … The need to have a no-testing arm in future trials is discussed. Thank you.

210. Disposition of Comments for CER 222: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
     December 03, 2019 - This point is discussed in the Future Research Needs section of the report.

211. Disposition of Comments for Technical Brief 36: Strategies for Patient, Family, and Caregiver Engagement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-36-patient-engagement-comments.pdf
     August 26, 2020 - Our team, including our medical illustrator/designer, discussed these suggestions and we elected to … Our team, including our medical illustrator/designer, discussed these suggestions and we elected to

212. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - can lead to higher fracture rates… We believe it is important to differentiate the "most commonly discussed … Five of the most commonly discussed include age, prior history of fracture, dosing frequency, concomitant … These issues were discussed in a recent review. Baron R, Ferrari S, Russell RG. … conclusion that “…the issue now seems settled that treatment with any of the FDA- approved agents discussed … the report clinically meaningful} The report provides clinically meaningful information; however, as discussed

213. Disposition of Comments: Comparative Effectiveness Review 235_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD-Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
     November 04, 2020 - Disposition of Comments: Comparative Effectiveness Review 235_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD-Repository Evidence Base Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Pharmacologic and Nonpharmac…

214. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - We have also reanalyzed the pregabalin data including unpublished results, as discussed above Public

215. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - We have also reanalyzed the pregabalin data including unpublished results, as discussed above Public

216. Disposition of Comments for Use of Natriuretic Peptide Measurement in the Management of Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
     November 20, 2013 - A recent review paper (Heart Fail Rev (2012) 17:81–96 ) discussed the topic in reasonable detail. … The standard for HF diagnosis has been revised in the Introduction and discussed under comment 90. … Main points were discussed. … Nesiridie (hBNP) was not discussed but it was probably not the objective of the review. … I also think that these figures can be removed, as they are not discussed in the text and they don't

217. Disposition of Comments Report for Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
     September 23, 2014 - We discussed some limitations of our inclusion criteria in the Discussion section. … than the perverbial coin toss, and this is very important as LN involvement by imaging is routinely discussed … The role of FNA should be discussed. … In addition, imaging modalities are discussed. … Harms of CT, such as those that may be influenced by dose, were discussed in Key Question 3 on harms

218. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
     October 01, 2010 - None of the authors has a financial interest in any of the products discussed in this document. … Results We first discussed considerations for deciding whether to combine studies, followed by discussions … Therefore, we recommend random effects models, with exceptions for rare binary outcomes (discussed … choose to use exact methods but we don‘t specifically recommend exact methods over fixed effect models discussed … As discussed earlier, tests of statistical heterogeneity should not be the only consideration for the

219. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
     October 01, 2010 - None of the authors has a financial interest in any of the products discussed in this document. … Results We first discussed considerations for deciding whether to combine studies, followed by discussions … Therefore, we recommend random effects models, with exceptions for rare binary outcomes (discussed … choose to use exact methods but we don‘t specifically recommend exact methods over fixed effect models discussed … As discussed earlier, tests of statistical heterogeneity should not be the only consideration for the

220. Considering the Range of Decision-Relevant Effects (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
     June 01, 2012 - (Genetic and prognostic tests are discussed further in modules 11 and 12.) Overview Segal JB. … Genetic tests are then further discussed in module 11, while prognostic tests are further discussed in … Patient preference was not discussed. … The other categories of outcomes that were discussed are emotional, social, cognitive, and behavioral